Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
[Cancer Research 59, 5425-5428, November 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuqua, S. A. W.
Right arrow Articles by Moore, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuqua, S. A. W.
Right arrow Articles by Moore, J. T.
[Cancer Research 59, 5425-5428, November 1, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Expression of Wild-Type Estrogen Receptor {beta} and Variant Isoforms in Human Breast Cancer1

Suzanne A. W. Fuqua2, Rachel Schiff, Irma Parra, William E. Friedrichs, Jui-Lan Su, David D. McKee, Kimberly Slentz-Kesler, Linda B. Moore, Timothy M. Willson and John T. Moore

Department of Medicine, Baylor College of Medicine, Houston, Texas 77030 [S. A. W. F., R. S., I. P., W. E. F.], and Departments of Molecular Sciences, Molecular Endocrinology and Medicinal Chemistry, Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709-3398 [J-L. S., D. D. M., K. S-K., L. B. M., T. M. W., J. T. M.]

It has been shown in previous studies that a variety of estrogen receptor (ER) {beta} mRNA transcripts are expressed in human breast cancer cell lines and tumors. To complement the RNA expression studies, we have developed ER-{beta}-specific antibodies to characterize ER-{beta} protein expression in breast cancer cell lines and tumors. Monoclonal antibodies were made against a peptide representing the first 18 amino acids of the longest ER-{beta} open reading frame reported to date, and polyclonal antibodies were made against a peptide within the ER-{beta} B domain. By Western blot analysis, we show that ER-{beta} protein is expressed in all cancer cell lines tested and in three of five breast tumor samples. The breast cancer cell lines showed variation in the size of the expressed ER-{beta} protein. The longest form detected was consistent with the 530-amino acid, full-length ER-{beta} sequence. Shorter ER-{beta} isoforms were detected in the ER-{alpha}-negative MDA-MB-231 and MDA-MB-435 breast cancer cell lines, likely corresponding to previously described COOH-terminal RNA variant isoforms.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
K. A. Mattingly, M. M. Ivanova, K. A. Riggs, N. S. Wickramasinghe, M. J. Barch, and C. M. Klinge
Estradiol Stimulates Transcription of Nuclear Respiratory Factor-1 and Increases Mitochondrial Biogenesis
Mol. Endocrinol., March 1, 2008; 22(3): 609 - 622.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S Borgquist, C Holm, M Stendahl, L Anagnostaki, G Landberg, and K Jirstrom
Oestrogen receptors {alpha} and show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer
J. Clin. Pathol., February 1, 2008; 61(2): 197 - 203.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
H. Sugiura, T. Toyama, Y. Hara, Z. Zhang, S. Kobayashi, Y. Fujii, H. Iwase, and H. Yamashita
Expression of Estrogen Receptor Wild-type and its Variant ER cx/ 2 is Correlated with Better Prognosis in Breast Cancer
Jpn. J. Clin. Oncol., November 1, 2007; 37(11): 820 - 828.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, et al.
Estrogen Receptors: How Do They Signal and What Are Their Targets
Physiol Rev, July 1, 2007; 87(3): 905 - 931.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Zhao, J. Matthews, M. Tujague, J. Wan, A. Strom, G. Toresson, E. W-F. Lam, G. Cheng, J.-A. Gustafsson, and K. Dahlman-Wright
Estrogen Receptor {beta}2 Negatively Regulates the Transactivation of Estrogen Receptor {alpha} in Human Breast Cancer Cells
Cancer Res., April 15, 2007; 67(8): 3955 - 3962.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
K. Dahlman-Wright, V. Cavailles, S. A. Fuqua, V. C. Jordan, J. A. Katzenellenbogen, K. S. Korach, A. Maggi, M. Muramatsu, M. G. Parker, and J.-A. Gustafsson
International Union of Pharmacology. LXIV. Estrogen Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 773 - 781.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
K. A. Riggs, N. S. Wickramasinghe, R. K. Cochrum, M. B. Watts, and C. M. Klinge
Decreased Chicken Ovalbumin Upstream Promoter Transcription Factor II Expression in Tamoxifen-Resistant Breast Cancer Cells.
Cancer Res., October 15, 2006; 66(20): 10188 - 10198.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
L. C Murphy and P. H Watson
Is oestrogen receptor- {beta} a predictor of endocrine therapy responsiveness in human breast cancer?
Endocr. Relat. Cancer, June 1, 2006; 13(2): 327 - 334.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Y. Savinov, A. G. Remacle, V. S. Golubkov, M. Krajewska, S. Kennedy, M. J. Duffy, D. V. Rozanov, S. Krajewski, and A. Y. Strongin
Matrix Metalloproteinase 26 Proteolysis of the NH2-Terminal Domain of the Estrogen Receptor {beta} Correlates with the Survival of Breast Cancer Patients.
Cancer Res., March 1, 2006; 66(5): 2716 - 2724.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Poola, S. A.W. Fuqua, R. L. De Witty, J. Abraham, J. J. Marshallack, and A. Liu
Estrogen Receptor {alpha}-Negative Breast Cancer Tissues Express Significant Levels of Estrogen-Independent Transcription Factors, ER{beta}1 and ER{beta}5: Potential Molecular Targets for Chemoprevention
Clin. Cancer Res., October 15, 2005; 11(20): 7579 - 7585.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
N. C. Peterson, M. D. Servinsky, A. Christian, Z. Peng, W. Qiu, J. Mann, J. Dicello, and D. L. Huso
Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model
Carcinogenesis, September 1, 2005; 26(9): 1542 - 1552.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Esslimani-Sahla, A. Kramar, J. Simony-Lafontaine, M. Warner, J.-A. Gustafsson, and H. Rochefort
Increased Estrogen Receptor {beta}cx Expression during Mammary Carcinogenesis
Clin. Cancer Res., May 1, 2005; 11(9): 3170 - 3174.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
L C Murphy, B Peng, A Lewis, J R Davie, E Leygue, A Kemp, K Ung, M Vendetti, and R Shiu
Inducible upregulation of oestrogen receptor-{beta}1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells
J. Mol. Endocrinol., April 1, 2005; 34(2): 553 - 566.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. M. Klinge, K. A. Blankenship, K. E. Risinger, S. Bhatnagar, E. L. Noisin, W. K. Sumanasekera, L. Zhao, D. M. Brey, and R. S. Keynton
Resveratrol and Estradiol Rapidly Activate MAPK Signaling through Estrogen Receptors {alpha} and {beta} in Endothelial Cells
J. Biol. Chem., March 4, 2005; 280(9): 7460 - 7468.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Ring and M. Dowsett
Mechanisms of tamoxifen resistance
Endocr. Relat. Cancer, December 1, 2004; 11(4): 643 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. A. Hopp, H. L. Weiss, I. S. Parra, Y. Cui, C. K. Osborne, and S. A. W. Fuqua
Low Levels of Estrogen Receptor {beta} Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer
Clin. Cancer Res., November 15, 2004; 10(22): 7490 - 7499.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
J. Martin de las Mulas, J. Ordas, M. Y. Millan, F. Chacon, M. De Lara, A. Espinosa de los Monteros, C. Reymundo, and A. Jover
Immunohistochemical Expression of Estrogen Receptor {beta} in Normal and Tumoral Canine Mammary Glands
Vet. Pathol., May 1, 2004; 41(3): 269 - 272.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. L. Ramsey, K. E. Risinger, S. C. Jernigan, K. A. Mattingly, and C. M. Klinge
Estrogen Receptor {beta} Isoforms Exhibit Differences in Ligand-Activated Transcriptional Activity in an Estrogen Response Element Sequence-Dependent Manner
Endocrinology, January 1, 2004; 145(1): 149 - 160.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. Patrone, T. N. Cassel, K. Pettersson, Y.-S. Piao, G. Cheng, P. Ciana, A. Maggi, M. Warner, J.-A. Gustafsson, and M. Nord
Regulation of Postnatal Lung Development and Homeostasis by Estrogen Receptor {beta}
Mol. Cell. Biol., December 1, 2003; 23(23): 8542 - 8552.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Sapino, P. Cassoni, E. Ferrero, M. Bongiovanni, L. Righi, N. Fortunati, P. Crafa, R. Chiarle, and G. Bussolati
Estrogen Receptor {alpha} Is a Novel Marker Expressed by Follicular Dendritic Cells in Lymph Nodes and Tumor-Associated Lymphoid Infiltrates
Am. J. Pathol., October 1, 2003; 163(4): 1313 - 1320.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
J. Matthews and J.-A. Gustafsson
Estrogen Signaling: A Subtle Balance Between ER{alpha} and ER{beta}
Mol. Interv., August 1, 2003; 3(5): 281 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
N. R. Bianco, G. Perry, M. A. Smith, D. J. Templeton, and M. M. Montano
Functional Implications of Antiestrogen Induction of Quinone Reductase: Inhibition of Estrogen-Induced Deoxyribonucleic Acid Damage
Mol. Endocrinol., July 1, 2003; 17(7): 1344 - 1355.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. W. Fuqua, R. Schiff, I. Parra, J. T. Moore, S. K. Mohsin, C. K. Osborne, G. M. Clark, and D. C. Allred
Estrogen Receptor {beta} Protein in Human Breast Cancer: Correlation with Clinical Tumor Parameters
Cancer Res., May 15, 2003; 63(10): 2434 - 2439.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Wu, Y. Wu, B. Gathings, M. Wan, X. Li, W. Grizzle, Z. Liu, C. Lu, Z. Mao, and X. Cao
Smad4 as a Transcription Corepressor for Estrogen Receptor alpha
J. Biol. Chem., April 18, 2003; 278(17): 15192 - 15200.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. R. D. Johnston, J. Head, S. Pancholi, S. Detre, L.-A. Martin, I. E. Smith, and M. Dowsett
Integration of Signal Transduction Inhibitors with Endocrine Therapy: An Approach to Overcoming Hormone Resistance in Breast Cancer
Clin. Cancer Res., January 1, 2003; 9(1): 524S - 532S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. M. Brownson, N. G. Azios, B. K. Fuqua, S. F. Dharmawardhane, and T. J. Mabry
Flavonoid Effects Relevant to Cancer
J. Nutr., November 1, 2002; 132(11): 3482S - 3489.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. T. K. Saunders, M. R. Millar, S. Macpherson, D. S. Irvine, N. P. Groome, L. R. Evans, R. M. Sharpe, and G. A. Scobie
ER{beta}1 and the ER{beta}2 Splice Variant (ER{beta}cx/{beta}2) Are Expressed in Distinct Cell Populations in the Adult Human Testis
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2706 - 2715.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. L. Gadd, G. Hobbs, and M. R. Miller
Acetaminophen-Induced Proliferation of Estrogen-Responsive Breast Cancer Cells Is Associated with Increases in c-myc RNA Expression and NF-{kappa}B Activity
Toxicol. Sci., April 1, 2002; 66(2): 233 - 243.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
G. J. Pepe, R. B. Billiar, M. G. Leavitt, N. C. Zachos, J. A. Gustafsson, and E. D. Albrecht
Expression of Estrogen Receptors {alpha} and {beta} in the Baboon Fetal Ovary
Biol Reprod, April 1, 2002; 66(4): 1054 - 1060.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. V. Jensen, G. Cheng, C. Palmieri, S. Saji, S. Makela, S. Van Noorden, T. Wahlstrom, M. Warner, R. C. Coombes, and J.-A. Gustafsson
Estrogen receptors and proliferation markers in primary and recurrent breast cancer
PNAS, November 29, 2001; (2001) 211556298.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Saji, H. Sakaguchi, S. Andersson, M. Warner, and J.-A. Gustafsson
Quantitative Analysis of Estrogen Receptor Proteins in Rat Mammary Gland
Endocrinology, July 1, 2001; 142(7): 3177 - 3186.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. G. Horvath, S. M. Henshall, C-S. Lee, D. R. Head, D. I. Quinn, S. Makela, W. Delprado, D. Golovsky, P. C. Brenner, G. O'Neill, et al.
Frequent Loss of Estrogen Receptor-{beta} Expression in Prostate Cancer
Cancer Res., July 1, 2001; 61(14): 5331 - 5335.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Leav, K.-M. Lau, J. Y. Adams, J. E. McNeal, M.-E. Taplin, J. Wang, H. Singh, and S.-M. Ho
Comparative Studies of the Estrogen Receptors {beta} and {{alpha}} and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma
Am. J. Pathol., July 1, 2001; 159(1): 79 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Swami, A. V. Krishnan, and D. Feldman
1{{alpha}},25-Dihydroxyvitamin D3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells
Clin. Cancer Res., August 1, 2000; 6(8): 3371 - 3379.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Speirs, I. P. Adams, D. S. Walton, and S. L. Atkin
Identification of Wild-Type and Exon 5 Deletion Variants of Estrogen Receptor {beta} in Normal Human Mammary Gland
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1601 - 1605.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
Q. Zhou, Z. K. Melkoumian, A. Lucktong, M. Moniwa, J. R. Davie, and J. S. Strobl
Rapid Induction of Histone Hyperacetylation and Cellular Differentiation in Human Breast Tumor Cell Lines following Degradation of Histone Deacetylase-1
J. Biol. Chem., November 3, 2000; 275(45): 35256 - 35263.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. V. Jensen, G. Cheng, C. Palmieri, S. Saji, S. Makela, S. Van Noorden, T. Wahlstrom, M. Warner, R. C. Coombes, and J.-A. Gustafsson
Estrogen receptors and proliferation markers in primary and recurrent breast cancer
PNAS, December 18, 2001; 98(26): 15197 - 15202.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.